target volume
Showing 1 - 25 of >10,000
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- New-mode reduce-volume target IMRT
- (no location specified)
Oct 18, 2023
Omitting Clinical Target Volume in Radical Treatment of
Not yet recruiting
- Immunotherapy
- +3 more
- IMRT+adjuvant immunotherapy
- (no location specified)
Jun 9, 2023
Uterine Cervical Tumors Trial in Gent (treatment with EXIT-target volume)
Completed
- Uterine Cervical Neoplasms
- treatment with EXIT-target volume
-
Gent, BelgiumRadiotherapy Department Ghent University Hospital
Dec 16, 2022
Glioblastoma Trial (New delineation approach)
Not yet recruiting
- Glioblastoma
- New delineation approach
- (no location specified)
Aug 22, 2022
Omitting Clinical Target Volume of Unresectable Stage III
Completed
- Stage III Non-small-cell Lung Cancer
- The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.
- (no location specified)
Aug 29, 2022
DETECT: Target Volume for Rectal Endoluminal Radiation Boosting
Recruiting
- Rectal Cancer
- Ultrasound
- +2 more
-
Maastricht, Limburg, Netherlands
- +2 more
Aug 24, 2022
Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)
Not yet recruiting
- Advanced Non-Small Cell Squamous Lung Cancer
- +2 more
- CTV omitted or delineated
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 7, 2023
Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Adaptive, two-phase RT
- (no location specified)
Feb 8, 2023
FDG-PET/CT for Simulation and Radiation Treatment Planning of
Active, not recruiting
- Breast Neoplasm
-
Geneva, SwitzerlandRadiation oncology, Geneva University Hospitals
Dec 18, 2022
Prostate Cancer Trial in Grenoble (Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose
Not yet recruiting
- Prostate Cancer
- Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D
-
Grenoble, FranceIsabelle Boudry
Apr 1, 2022
Glioma Trial in Ann Arbor (High Dose Radiation, Temozolomide)
Completed
- Glioma
- High Dose Radiation
- Temozolomide
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Mar 21, 2021
Hepatic Metastasis Trial in Heidelberg (ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT), MRgSBRT
Recruiting
- Hepatic Metastasis
- ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT)
- MRgSBRT (Magnetic Resonance-guided Stereotactic Body Radiotherapy)
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Aug 25, 2021
Respiratory Failure Trial (Respiratory support a, Respiratory support b)
Not yet recruiting
- Respiratory Failure
- Respiratory support a
- Respiratory support b
- (no location specified)
Apr 24, 2023
Preventing Malnutrition Trial in Erzincan (Gastric residual volume measurement stopped.)
Completed
- Preventing Malnutrition
- Gastric residual volume measurement stopped.
-
Erzincan, TurkeyErzincan Binali Yildirim university
Feb 11, 2022
Kidney Transplant; Complications, Renal Failure Chronic Trial in Seoul (Crystalloid fluid administration with the target of
Completed
- Kidney Transplant; Complications
- Renal Failure Chronic
- Crystalloid fluid administration with the target of stroke volume variation ≤ 12%
- Crystalloid fluid administration with the target of stroke volume variation ≤ 6%
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 20, 2021
Prostate Cancer Adenocarcinoma Trial in United States (30Gy (Gray) planning target volume (PTV))
Recruiting
- Prostate Cancer Adenocarcinoma
- 30Gy (Gray) planning target volume (PTV)
-
San Francisco, California
- +7 more
Jun 28, 2022
3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent
Recruiting
- Recurrent Rectal Cancer
- +2 more
- CTV
-
Beijing, Beijing, ChinaPeking Unnversity Third Hospital
Jan 13, 2021
Blood Pressure, Complication,Postoperative, Intraoperative Hypotension Trial in Italy (Ephedrine, Norepinephrine, Etilefrine
Not yet recruiting
- Blood Pressure
- +2 more
- Ephedrine
- +3 more
-
Chieti, Abruzzo, Italy
- +7 more
Dec 4, 2022
Rationality of International Guideline About Selective Coverage
Not yet recruiting
- Nasopharyngeal Carcinoma
- IB-positive group
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Apr 28, 2021
Radiotherapy, Nonsmall Cell Lung Cancer, Stage IV Trial in Guiyang (Drug therapy concurrent radiotherapy for primary tumor
Not yet recruiting
- Radiotherapy
- Nonsmall Cell Lung Cancer, Stage IV
- Drug therapy concurrent radiotherapy for primary tumor omitted CTV
-
Guiyang, Guizhou, ChinaAffiliated Hospital of Guizhou Medical University
Dec 3, 2020
Nasopharyngeal Tumors Trial in Guangzhou (IMRT using individualized CTV, IMRT using traditional CTV, Gemcitabine and cisplatin
Unknown status
- Nasopharyngeal Neoplasms
- IMRT using individualized CTV
- +5 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 13, 2020
Glioblastoma, Glioblastoma Multiforme Trial in Iowa City (External beam radiation therapy)
Withdrawn
- Glioblastoma
- Glioblastoma Multiforme
- External beam radiation therapy
-
Iowa City, IowaUniversity of Iowa Department of Radiation Oncology
Sep 4, 2020
NSCLC, Radiation Therapy, Locally Advanced Disease Trial in Lyon (mid-position radiation strategy, ITV)
Completed
- Non-small Cell Lung Cancer
- +4 more
- mid-position radiation strategy
- ITV
-
Lyon, FranceCentre Léon Bérard
Feb 4, 2021
Modified Reduce-volume Target IMRT in Treatment of
Completed
- Nasopharyngeal Carcinoma
- modified reduce-volume target IMRT
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 7, 2020
COPD Trial in Izmir (Minute volume target of 100%, Minute volume target to reach PaCO2 less than 45% (high tidal volume))
Unknown status
- Chronic Obstructive Pulmonary Disease
- Minute volume target of 100%
- Minute volume target to reach PaCO2 less than 45% (high tidal volume)
-
Izmir, Yenisehir, TurkeyIzmir Dr. Suat Seren Chest Diseases and Surgery Education and Re
Dec 21, 2020